Evidence map›Paper›PMID 42020904›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Culture of Human Retinal Explants as an Ex Vivo Model for Retinal Gene Therapy.

Almaqdad Alsalloum, Madina Khubetsova, Olga Mityaeva, Pavel Volchkov

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Almaqdad AlsalloumMoscow Institute of Physics and Technology, Dolgoprudny, Russia.ORCID https://orcid.org/0000-0002-9698-0634
Madina KhubetsovaS.N. Fedorov National Ophthalmology Medical Research Center "Eye Microsurgery", Moscow, Russia.ORCID https://orcid.org/0000-0002-6378-8750
Olga MityaevaMoscow Institute of Physics and Technology, Dolgoprudny, Russia.ORCID https://orcid.org/0000-0001-9252-1601
Pavel VolchkovMoscow Institute of Physics and Technology, Dolgoprudny, Russia.ORCID https://orcid.org/0000-0001-9794-6297

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Optogenetic gene therapy may employ recombinant adeno-associated virus (AAV) vectors for specific preclinical applications in the treatment of inherited retinal diseases. Human retinal explants as an ex vivo model assist determine cellular tropism and the level of subsequent gene expression followed by delivery of viral vectors. Extracts of retinal tissue can be obtained and cultured for a certain time; thus, it is possible to transduce and confirm the effectiveness of the virus using various methods, including immunohistochemical staining. Consequently, we described method for harvesting and culturing human retinal fragments from divergent parts of the retina that differ anatomically and molecularly. The fragments were fixed, sectioned, and stained. A dissociation method has also been described to obtain a retinal cell suspension that can be used in other experiments such as flow cytometry or mRNA/protein level expression assays.

Indexed as

Genetic TherapyRetinaRetinal DiseasesTissue Culture TechniquesDependovirusGenetic VectorsHumansTransduction, GeneticAAV tropismCulturingDissociationGene therapyHuman retinal explants

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.